CompoAtlas

BROMILASE (60 COMPRIMÉS)

Food supplement declared in France, decision dated 28 October 2026

BROMILASE (60 COMPRIMÉS) (DIGI-PHARM) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: bromélaïne 100 mg per day, Melilotus officinalis 150 mg per day, Aesculus hippocastanum 150 mg per day, Centella asiatica 100 mg per day, Equisetum arvense 100 mg per day. None of the rules we check flags an issue with its declared composition.

Brand
DIGI-PHARM
Food business operator placing the product on the market
DIGI-PHARM S.R.L
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Tablet
Daily dose
1 COMPRIMÉ PAR JOUR.
Directions for use
Prendre 1 comprimé par jour.
Intended populations
Men and women aged 18 and over
Not recommended (according to the manufacturer)
Breastfeeding women, Pregnant women, Kidney failure, Heart problems, Taking anticoagulants
Objectives stated by the manufacturer (these are not authorised claims)
Autre : AUCUN

Declaration 379810, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Melilotus officinalis (L.) Pall.Sommités fleuriesExtrait sec aqueux150 mg
Aesculus hippocastanum L.GraineExtrait sec aqueux150 mg
Centella asiatica (L.) Urb.Parties aériennesExtrait sec aqueux100 mg
Equisetum arvense L.Parties aériennesExtrait sec aqueux100 mg

Substances

NamePer day
bromélaïne100 mg

Additives

E551, E463, E470b, E460

Other ingredients

maltodextrine

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Produit réservé aux adultes. Les compléments alimentaires ne peuvent pas être utilisés comme substituts d’un régime alimentaire varié et équilibré ni d’un mode de vie sain. Tenir hors de portée des jeunes enfants. Ne pas dépasser la dose journalière recommandée. Déconseillé en cas d’insuffisance cardiaque, rénale œdémateuse, ou sous traitement anticoagulant. Déconseillé aux femmes enceintes ou allaitantes. Ne pas utiliser le produit si l’emballage n’est pas intact.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Aesculus hippocastanum L.
    Read the warning, when it applies and the studies cited

    Horse Chestnut - Aesculus Hippocastanum

    Route of administration: Oral (Bradley 2006; ESCOP 2003)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Brinker 2010; Mills and Bone 2005).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    Known adverse reactions

    When using this product you may experience headache, dizziness, gastric irritation, or itchiness (Bradley 2006; Mills and Bone 2005; ESCOP 2003).

    Sources cited by Health Canada (3)
    • Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (UK): British Herbal Medicine Association; 2006.
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    Health Canada monograph dated 27 February 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : DIGI-PHARM

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “BROMILASE (60 COMPRIMÉS) (DIGI-PHARM): composition and regulation”, https://compoatlas.com/en/supplements/products/379810-bromilase-60-comprimes, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line